#NASH

Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.

More than a third of hepatocellular carcinoma cases among Medicare recipients were due to fatty liver disease.

Higher daily alcohol consumption was linked to greater risk for MAFLD.

Noninvasive imaging may be the best way to screen for NAFLD in this population.

Abdominal obesity worsened the impact of air pollution on MAFLD development.

Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.

Research has shown that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of HCC.

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.

A companion study will look at liver biopsy results to confirm these findings from noninvasive tests.

The early cancer is detected, the easier it is to treat.

Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.

People with NAFLD have an elevated risk of cancer, largely due to high liver cancer incidence.

The disease has similar prevalence across high-income and low- and middle-income nations.

Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.

The diabetes medication, alone or in combination regimens, led to improvements in NASH and fibrosis.